DOCSLIB.ORG

Federal Register/Vol. 86, No. 129/Friday, July 9, 2021/Proposed

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Federal Register/Vol. 86, No. 129/Friday, July 9, 2021/Proposed 36322 Federal Register / Vol. 86, No. 129 / Friday, July 9, 2021 / Proposed Rules DEPARTMENT OF HEALTH AND the addresses provided below, by make threats to individuals or HUMAN SERVICES August 31, 2021. institutions or suggest that the ADDRESSES: In commenting, please refer individual will take actions to harm the Centers for Medicare & Medicaid to file code CMS–1749–P. Because of individual. CMS continues to encourage Services staff and resource limitations, we cannot individuals not to submit duplicative accept comments by facsimile (FAX) comments. We will post acceptable 42 CFR Parts 413 and 512 transmission. Comments, including comments from multiple unique mass comment submissions, must be commenters even if the content is [CMS–1749–P] submitted in one of the following three identical or nearly identical to other ways (please choose only one of the comments. RIN 0938–AU39 ways listed): Current Procedural Terminology (CPT) Copyright Notice: Throughout this Medicare Program; End-Stage Renal 1. Electronically. You may submit proposed rule, we use CPT® codes and Disease Prospective Payment System, electronic comments on this regulation descriptions to refer to a variety of Payment for Renal Dialysis Services to http://www.regulations.gov. Follow services. We note that CPT® codes and Furnished to Individuals With Acute the ‘‘Submit a comment’’ instructions. descriptions are copyright 2020 Kidney Injury, End-Stage Renal 2. By regular mail. You may mail American Medical Association (AMA). Disease Quality Incentive Program, written comments to the following All Rights Reserved. CPT® is a and End-Stage Renal Disease address ONLY: Centers for Medicare & registered trademark of the AMA. Treatment Choices Model Medicaid Services, Department of Health and Human Services, Attention: Applicable Federal Acquisition AGENCY: Centers for Medicare & CMS–1749–P, P.O. Box 8010, Baltimore, Regulations (FAR) and Defense Federal Medicaid Services (CMS), HHS. MD 21244–8010. Acquisition Regulations (DFAR) apply. ACTION: Proposed rule. Please allow sufficient time for mailed Table of Contents comments to be received before the SUMMARY: This proposed rule would close of the comment period. To assist readers in referencing update the End-Stage Renal Disease 3. By express or overnight mail. You sections contained in this preamble, we (ESRD) Prospective Payment System may send written comments to the are providing a Table of Contents. (PPS) for calendar year (CY) 2022. This following address ONLY: Centers for I. Executive Summary rulemaking also proposes to update the Medicare & Medicaid Services, A. Purpose payment rate for renal dialysis services Department of Health and Human B. Summary of the Major Provisions furnished by an ESRD facility to Services, Attention: CMS–1749–P, Mail C. Summary of Cost and Benefits individuals with acute kidney injury Stop C4–26–05, 7500 Security II. Calendar Year (CY) 2022 End-Stage Renal Disease (ESRD) Prospective Payment (AKI). In addition, this rulemaking Boulevard, Baltimore, MD 21244–1850. System (PPS) proposes to update requirements for the For information on viewing public A. Background ESRD Quality Incentive Program (QIP), comments, see the beginning of the B. Provisions of the Proposed Rule including a proposed measure SUPPLEMENTARY INFORMATION section. C. Proposed Transitional Add-On Payment suppression policy for the duration of FOR FURTHER INFORMATION CONTACT: Adjustment for New and Innovative the coronavirus disease 2019 (COVID– [email protected], for Equipment and Supplies (TPNIES) for 19) public health emergency (PHE) and issues related to the ESRD PPS and CY 2022 Payment as well as proposals to suppress III. Calendar Year (CY) 2022 Payment for coverage and payment for renal dialysis Renal Dialysis Services Furnished to individual ESRD QIP measures under services furnished to individuals with Individuals With Acute Kidney Injury that proposed measure suppression AKI. (AKI) policy. This proposed rule also [email protected], for A. Background announces an extension of time for issues related to the Transitional Add- B. Proposed Annual Payment Rate Update facilities to report September through On Payment Adjustment for New and for CY 2022 December 2020 ESRD QIP data under Innovative Equipment and Supplies IV. End-Stage Renal Disease Quality our Extraordinary Circumstances (TPNIES). Incentive Program (ESRD QIP) Exception (ECE) policy due to CMS A. Background Delia Houseal, (410) 786–2724, for B. Extraordinary Circumstances Exception operational issues, and proposes to not issues related to the ESRD QIP. (ECE) Previously Granted for the ESRD score facilities or reduce payment to any ETC–[email protected], for issues QIP and Notification of ECE Due to ESRD facility in PY 2022. In addition, this related to the ESRD Treatment Choices Quality Reporting System Issues proposed rule includes requests for (ETC) Model. C. Proposed Flexibilities for the ESRD QIP information on topics that are relevant SUPPLEMENTARY INFORMATION: in Response to the COVID–19 PHE to the ESRD QIP. Further, this rule also Inspection of Public Comments: All D. Proposed Special Scoring Methodology and Payment Policy for the PY 2022 proposes changes to the ESRD comments received before the close of Treatment Choices (ETC) Model, which ESRD QIP the comment period are available for E. Proposed Updates to Requirements is a mandatory payment model that is viewing by the public, including any Beginning With the PY 2024 ESRD QIP focused on encouraging greater use of personally identifiable or confidential F. Updates for the PY 2025 ESRD QIP home dialysis and kidney transplants, to business information that is included in G. Requests for Information (RFIs) on reduce Medicare expenditures while a comment. We post all comments Topics Relevant to ESRD QIP preserving or enhancing the quality of received before the close of the V. End-Stage Renal Disease Treatment care furnished to Medicare comment period on the following Choices (ETC) Model beneficiaries. Finally, this proposed rule website as soon as possible after they A. Background B. Provisions of the Proposed Rule includes several requests for have been received: http:// information to inform payment reform C. Requests for Information (RFIs) on www.regulations.gov. Follow the search Topics Relevant to ETC Model under the ESRD PPS. instructions on that website to view VI. Requests for Information DATES: To be assured consideration, public comments. CMS will not post on A. Informing Payment Reform Under the comments must be submitted at one of Regulations.gov public comments that ESRD PPS VerDate Sep<11>2014 19:30 Jul 08, 2021 Jkt 253001 PO 00000 Frm 00002 Fmt 4701 Sfmt 4702 E:\FR\FM\09JYP2.SGM 09JYP2 jbell on DSKJLSW7X2PROD with PROPOSALS2 Federal Register / Vol. 86, No. 129 / Friday, July 9, 2021 / Proposed Rules 36323 B. Technical Expert Panels (TEPs) 2. Coverage and Payment for Renal information on several important topics, C. Calculation of the Low-Volume Payment Dialysis Services Furnished to including strategies that CMS can use to Adjustment (LVPA) Individuals With Acute Kidney Injury address the gap in existing health D. Calculation of the Case-Mix (AKI) inequities, the addition of COVID–19 Adjustments On June 29, 2015, the President vaccination measures in future E. Calculation of the Outlier Payment signed the Trade Preferences Extension rulemaking, and the use of digital Adjustment quality measurement. F. Calculation of the Pediatric Dialysis Act of 2015 (TPEA) (Pub. L. 114–27). Payment Adjustment Section 808(a) of the TPEA amended 4. End-Stage Renal Disease Treatment G. Modifying the ESRD PPS and Hospital section 1861(s)(2)(F) of the Act to Choices (ETC) Model Cost Reports provide coverage for renal dialysis This rulemaking proposes to H. Modifying the Pediatric Cost Report services furnished on or after January 1, implement changes to the End-Stage I. Modifying Site of Services Provided to 2017, by a renal dialysis facility or a Renal Disease (ESRD) Treatment Medicare Beneficiaries with Acute provider of services paid under section Choices Model (ETC) Model, a Kidney Injury (AKI) 1881(b)(14) of the Act to an individual mandatory Medicare payment model VII. Collection of Information Requirements with acute kidney injury (AKI). Section tested under the authority of section A. Legislative Requirement for Solicitation 808(b) of the TPEA amended section 1115A of the Act. The ETC Model is of Comments 1834 of the Act by adding a new operated by the Center for Medicare and B. Requirements in Regulation Text subsection (r) that provides for payment Medicaid Innovation (Innovation C. Additional Information Collection for renal dialysis services furnished by Center), and tests the use of payment Requirements renal dialysis facilities or providers of adjustments to encourage greater VIII. Response to Comments services paid under section 1881(b)(14) utilization of home dialysis and kidney IX. Economic Analyses of the Act to individuals with AKI at the transplants, in order to preserve or A. Regulatory Impact Analysis ESRD PPS base rate beginning January enhance the quality of care furnished to B. Detailed Economic Analysis 1, 2017. This rule proposes to update Medicare beneficiaries while reducing C. Accounting Statement the AKI payment rate for CY 2022. Medicare expenditures. The ETC Model D. Regulatory Flexibility Act Analysis 3. End-Stage Renal Disease Quality includes ESRD facilities and certain (RFA) Incentive Program (ESRD QIP) clinicians caring for beneficiaries with E.
Load more

Recommended publications
  • KIDNEY FAILURE TREATMENT OPTIONS Choosing What’S Best for You What Kidneys Do
    KIDNEY FAILURE TREATMENT OPTIONS Choosing What’s Best For You What Kidneys Do The kidneys are a pair of bean shaped organs located below your ribcage near the middle of your back. Kidneys play a vital role in the body by filtering blood, removing waste and extra water, balancing electrolytes—sodium, potassium, chloride, and biacarbonate, and regulating blood pressure. As kidneys filter blood they create urine/wastes which collect in the bladder until you go to the bath- room. If your body doesn’t remove these wastes, they build up in the blood and damage the body. For most people this damage occurs slowly over many years causing Chronic Kidney Disease (CKD). CKD eventually results in End Stage Renal Disease (ESRD) which is when dialysis or a transplant becomes necessary. 2 TREATMENT OPTIONS Treatment Options This guide will cover four treatment options for your condition: l Hemodialysis (in-center & home) l Peritoneal Dialysis l Kidney Transplantation l Comfort Care Introduction When diagnosed with kidney disease, the key to feeling better is to follow the treatment plan developed by your doctor and other members of your care team including nurses, dietitians, and social workers. Following the advice of your medical professionals will help you lead the healthiest lifestyle possible. When your kidneys are unable to remove extra fluid and waste from the body, dialysis is generally recommended. Dialysis helps alleviate many of the health problems people with kidney failure experience. Dialysis can be done in a hospital, a dialysis clinic, or at home. Once you know all of your treatment options, you will make the decision of where you choose to have dialysis with the help of your doctor, other health care professionals, and your family.
    [Show full text]
  • Chronic Kidney Disease a Patient’S Guide
    Chronic Kidney Disease A Patient’s Guide WHAT IS CHRONIC KIDNEY DISEASE (CKD)? chronic kidney disease, have heart disease or are over 60 years CKD is a preventable and treatable disease. Controlling old, you are at higher risk of CKD and should be screened for diabetes and reducing blood pressure will help you live longer this problem. and feel better. HOW IS CHRONIC KIDNEY DISEASE DIAGNOSED? The kidneys are responsible for removing liquid waste from CKD is diagnosed with (1) a blood test and (2) a urine test. the body. They are basically the body’s water filtration system. The blood test is called a glomerular filtration rate or GFR. If CKD is becoming much more common. Up to 20 million the GFR is above 60, kidney function is adequate and the risks Americans have CKD. If it is not treated early, it causes of major complications are minimal. Although not perfect, the death from heart disease, or the need for an artificial kidney easy way to remember this is that you are SAFE AT 60. machine, called dialysis. The patient may also need a kidney If the urine test shows protein, OR a GFR less than 60, then transplant. Although kidney disease cannot be cured, it can your doctor can give you a medicine called an ACE inhibi- be controlled. With some simple steps, you and your doctor tor or an ARB. These medicines will protect you from having can help to prevent heart attacks. Also, the need for dialysis or your kidney disease worsen. ACE inhibitors always end with transplant can be significantly delayed and perhaps eliminated.
    [Show full text]
  • Home Dialysis
    Have you thought about DIALYSIS at There is more than one HOME? way to treat kidney failure. Choosing your treatment is about helping you live your life. GETTING INVOLVED REALLY MATTERS You’ll feel more in charge if you take an active role in the decision. Your kidney team should tell you about all treatment options and the pros and What are the first steps? cons of each. But you make Learn about the different options for treatment of kidney failure. the choice based on your n Talk to the professionals who are treating you. needs, lifestyle, medical n Ask questions: conditions, and current • What treatments are done at home? level of kidney function. In • Am I eligible for home treatments? • How will my choice of treatment affect my order to make this decision, health and lifestyle? you need to learn about all • At this point in my kidney disease, is one choice better than another? the treatments. • Will one treatment better protect my remaining kidney function? Which one? 2 Where can you learn about your options? When you have kidney disease, a team of professionals (your kidney team) will help you understand how your choice will affect your life. Ask questions to be sure what the right option is for you. Discuss the things that are most important to you and any concerns or worries you may have. Visit the National Kidney Foundation website at www.kidney.org for helpful resources. You can also call the NKF Cares patient help line toll-free at 1.855.NKF.CARES (1.855.653.2273) or email [email protected].
    [Show full text]
  • The Story of Organ Transplantation, 21 Hastings L.J
    Hastings Law Journal Volume 21 | Issue 1 Article 4 1-1969 The tS ory of Organ Transplantation J. Englebert Dunphy Follow this and additional works at: https://repository.uchastings.edu/hastings_law_journal Part of the Law Commons Recommended Citation J. Englebert Dunphy, The Story of Organ Transplantation, 21 Hastings L.J. 67 (1969). Available at: https://repository.uchastings.edu/hastings_law_journal/vol21/iss1/4 This Article is brought to you for free and open access by the Law Journals at UC Hastings Scholarship Repository. It has been accepted for inclusion in Hastings Law Journal by an authorized editor of UC Hastings Scholarship Repository. The Story of Organ Transplantation By J. ENGLEBERT DUNmHY, M.D.* THE successful transplantation of a heart from one human being to another, by Dr. Christian Barnard of South Africa, hias occasioned an intense renewal of public interest in organ transplantation. The back- ground of transplantation, and its present status, with a note on certain ethical aspects are reviewed here with the interest of the lay reader in mind. History of Transplants Transplantation of tissues was performed over 5000 years ago. Both the Egyptians and Hindus transplanted skin to replace noses destroyed by syphilis. Between 53 B.C. and 210 A.D., both Celsus and Galen carried out successful transplantation of tissues from one part of the body to another. While reports of transplantation of tissues from one person to another were also recorded, accurate documentation of success was not established. John Hunter, the father of scientific surgery, practiced transplan- tation experimentally and clinically in the 1760's. Hunter, assisted by a dentist, transplanted teeth for distinguished ladies, usually taking them from their unfortunate maidservants.
    [Show full text]
  • Choosing the Right Treatment Method – Exploring Home Dialysis Options
    Choosing the Right Treatment Method – Exploring Home Dialysis Options Presented by: Mikie Cooke, MSW, ACSW and Erick Smith Thanks to our speakers! Mikie Cooke, MSW, ACSW PATHfinder™ Satellite Healthcare Erick Smith PATHfinder™ Satellite Healthcare Learning Outcomes After this webinar attendees should understand: • The importance of goal setting when choosing a dialysis treatment option. • Hemodialysis, including home hemodialysis and why someone should choose this option. • Peritoneal dialysis and why someone should choose this option. Audience Poll What is your connection to kidney disease? 1. I have kidney disease 2. I am a family member or caregiver for someone with kidney disease 3. I work with patients with kidney disease If you work for a dialysis company, which company do you work for? 1. Fresenius 2. DaVita 3. Satellite 4. Other If you are a dialysis patient, which treatment method do you currently use? 1. In-center hemodialysis 2. Home hemodialysis 3. Peritoneal dialysis If you are a health care professional, which dialysis treatment method would you choose? 1. In-center hemodialysis 2. Home hemodialysis 3. Peritoneal dialysis The Importance of Goal Setting • What inspires you? • Inspiration leads to motivation • Motivation leads to change in behavior https://www.sandler.com/blog/motivation-and-discipline-how-managers-can-use- both-lead-successful-team Education • What type of water source would you like to drink out of? Steps to Starting • Education • Decision • Surgery • Healing • Training • Maintenance Why are we talking about this? Distribution of renal replacement therapy modality used by ESRD patients, by country, 2015 USA Qatar Denmark Australia Canada Colombia Thailand New Zealand Hong Kong 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% Peritoneal Dialysis Home Hemodialysis Transplant In-Center Hemodialysis Data from 2017 USRDS Annual Report; accessed on Nov.
    [Show full text]
  • What Is Kidney Failure?
    A VIDEO SERIES living WELL with kidney failure WHAT IS KIDNEY FAILURE? Contents 2 Introduction 11 What is a kidney transplant? 3 What will I learn? 12 What role do diet and medi- cines play in transplantation? 5 Who is on my healthcare team? 12 How will I pay for treatment? 7 What is kidney failure? 14 Review 7 How will I learn to cope 15 True or False with kidney failure? 16 Words To Know 8 What treatments are 21 The People on My available for kidney failure? Healthcare Team 8 What is the best 22 Questions for My treatment for me? Healthcare Team 9 What is hemodialysis? 23 About the National 10 What is peritoneal dialysis? Kidney Foundation 10 What role do diet and medicines play in dialysis? What is Kidney Failure? 1 Introduction “Living Well with Kidney Failure” is a video series created by the National Kidney Foundation to help you understand kidney failure and its treatments. There are six videos. Each video has a companion booklet to provide more information and to help you review what you’ve learned. The six videos and booklets are: How Kidney What is Failure Kidney Peritoneal Kidney Hemodialysis Living Well Affects Your Transplant Dialysis Failure? Body This booklet talks about the treatments available for kidney failure. It also describes the professionals who make up the healthcare team in hospitals, dialysis centers, and transplant centers. But, more importantly, it focuses on the role you play in your own care. That role begins with learning all you can about kidney failure and its treatment.
    [Show full text]
  • Writing the Home Hemodialysis (HHD) Prescription
    ASN DIALYSIS ADVISORY GROUP ASN DIALYSIS CURRICULUM This image cannot currently be displayed. Writing the Home Hemodialysis (HHD) Prescription Joel D. Glickman, MD • Professor of Clinical Medicine • Perelman School of Medicine • University of Pennsylvania 2 This image cannot currently be displayed. Goals For A Successful HHD Prescription • SOLUTE REMOVAL • Small solute target: std Kt/V > 2.0 • Achieved with lower spKt/V than in-center HD • For 5 treatment per week target spKt/V ~ 0.55 - 0.60 • For 6 treatment per week target spKt/V ~ 0.45 • Phosphate clearance • Middle Molecule clearance • FLUID REMOVAL • Avoid high ultrafiltration rates • QUALITY OF LIFE • Need to match prescription to patient lifestyle 3 This image cannot currently be displayed. Typical Treatment Parameters For HHD NxStage Traditional Equipment “Low dialysate volume approach” Conventional SDHD* NHD** SDHD NHD HD Treatments/Wk 3 5-6 5-6 5-6 5-6 Treatment 4 2 6-8 2.25-3 6-8 Time (Hrs) Qb (ml/Min) 400 400 200-250 400 200-250 Qd (ml/Min) 600-800 600-800 300 130-200 60-80 * SDHD = short daily hemodialysis ** NHD = nocturnal hemodialysis 4 This image cannot currently be displayed. SDHD - Traditional technology . 5 Approach is exactly the same as in-center HD • Clearance • Qb 400; Qd 600 • Typical spKt/V ~ 0.8 • Time on therapy • 2 hours – adjust to achieve target clearance • Potassium • Adjust according to blood test results • Bicarbonate • Adjust according to blood test results • Calcium • Adjust according to blood test results • Heparin • Bolus 1500-3000 units This image cannot currently be displayed. New Technology Technology should adapt to patient’s needs.
    [Show full text]
  • An Implantable Bioartificial Kidney for Treating Kidney Failure
    DIALYSIS ACCESS An Implantable Bioartificial Kidney for Treating Kidney Failure An innovative device that aims to provide the benefits of kidney transplantation while addressing the limited number of donor organs. BY SHUVO ROY, PHD, AND WILLIAM FISSELL, MD nd-stage renal disease (ESRD) currently affects over nection, the bioartificial kidney processes blood continu- 600,000 people in the United States, with fewer than ously, which mitigates the inconveniences and morbidities 20,000 donor organs available for transplant. This is a associated with intermittent hemodialysis. growing problem as the number of patients on the The bioartificial kidney is a two-stage system that consists Etransplant wait list is hovering at 100,000, and the prevalent of (1) a hemofiltration unit to remove toxins and (2) a renal ESRD population is increasing at 4% to 5% annually.1,2 At cell bioreactor to provide other biological functions of a present, the only alternative to kidney transplant for the healthy kidney.3 For the hemofilter, silicon nanotechnology vast majority of patients with ESRD is hemodialysis, a proce- is used to produce a highly efficient and compact mem- dure fraught with morbidity and eventual mortality. After brane, which relies on the body’s blood pressure to perform vascular access is established in the form of an arteriovenous ultrafiltration without the need for pumps or power sup- fistula, arteriovenous graft, or venous catheter, a typical in- ply. For the cell bioreactor, recent advances in the field of center hemodialysis schedule is three sessions per week for regenerative medicine are applied to grow renal tubule 3 to 5 hours per session, in which blood is pumped through cells to perform metabolic functions.
    [Show full text]
  • Technological Advances in Renal Replacement Therapy: Five Years and Beyond
    Technological Advances in Renal Replacement Therapy: Five Years and Beyond Anjay Rastogi* and Allen R. Nissenson† *Division of Nephrology, Department of Medicine, University of California, Los Angeles, Los Angeles, California; and †Office of the Chief Medical Officer, DaVita Inc., El Segundo, California The worldwide epidemic of chronic kidney disease shows no signs of abating in the near future. Current dialysis forms of renal replacement therapy (RRT), even though successful in sustaining life and improving quality of life somewhat for patients with ESRD, have many limitations that result in still unacceptably high morbidity and mortality. Transplantation is an excellent option but is limited by the scarcity of organs. An ideal form of RRT would mimic the functions of natural kidneys and be transparent to the patient, as well as affordable to society. Recent advances in technology, although generally in early stages of development, might achieve these goals. The application of nanotechnology, microfluidics, bioreactors with kidney cells, and miniaturized sorbent systems to regenerate dialysate makes clinical reality seem closer than ever before. Finally, stem cells hold much promise, both for kidney disease and as a source of tissues and organs. In summary, nephrology is at an exciting crossroad with the application of innovative and novel technologies to RRT that hold considerable promise for the near future. Clin J Am Soc Nephrol 4: S132–S136, 2009. doi: 10.2215/CJN.02860409 he ongoing worldwide epidemic of chronic kidney dis- more user-friendly delivery systems. In PD, introduction of ease (CKD) includes ESRD. According to recent US automated cyclers has improved convenience of the technique T Renal Data System estimates, more than 900,000 pa- for some patients, increased the practical volume of dialysate, tients worldwide have ESRD and are on renal replacement and, therefore, increased solute clearance and ultrafiltration therapy (RRT) (1).
    [Show full text]
  • July-August 2000 Medicare B Update
    Important Information ! for Readers of the Medicare B Update! his issue marks the final publication that will be printed for the Tremainder of the current fiscal year that ends September 30, 2000. There will not be a printed September/October 2000 issue. The September/October 2000 edition will be available on our website, www.floridamedicare.com. This will allow readers of the Update! to access date sensitive information more quickly than is possible via traditionally-published materials. Effective for fiscal year 2001, the Update! will be produced on a quarterly basis. The initial quarterly issue of the Update! will be for the pdate first quarter of calendar year 2000, and will be available in mid-November. It will provide information that will be effective January 1, 2001, including the 2001 HCPCS changes. The quarterly format Update! will be provided to readers approximately forty-five days prior to implementation of HCFAs quarterly system releases. Additionally, the website will be updated throughout the quarter between publications to ensure providers are furnished with the latest information in plenty of time to allow them to U make necessary changes. These in-between items will soon be found in a new Hot Topics! section within the Part B Publications area of the website. Information posted to the website in this manner will be provided in the subsequent quarterly issue of the Update! lease share the Medicare B Features PUpdate! with appropriate members of your organization. From the Medical Director 3 Routing Suggestions: Administrative 4 o Physician/Provider Claims 5 Coverage/Reimbursement 6 o Office Manager Local and Focused Medical Review 25 o Biller/Vendor Electronic Media Claims 67 General Information 68 o Nursing Staff Educational Resources 72 o Other __________ Index 79 __________ __________ __________ __________ __________ FIRST COAST __________ __________ Health Care Financing Administration SERVICE OPTIONS, INC.
    [Show full text]
  • Renal Replacement Therapy: Options and Choices
    Renal Replacement Therapy: Options and Choices Marc L. Weber, M.D. Nephrologist University of Minnesota Minneapolis, MN That disclosure slide… • I have no financial or other disclosures and will not discuss off label use of any medication. Learning Objectives • Identity renal replacement therapy options for patients with end stage renal disease (ESRD). Self Assessment Questions • 1. Renal replacement therapy should be considered if the patient is experiencing: o A. Hyperkalemia o B. Metabolic acidosis o C. Fluid overload o D. All of the above • 2. Types of Hemodialysis access include: o A. Fistula o B. Graft o C. Catheter o D. All of the above Indications for Renal Replacement Therapy • Hyperkalemia* • Metabolic acidosis* • Fluid overload (recurrent CHF admissions)* • Uremic pericarditis (rub) • Other non specific uremic symptoms: anorexia and nausea, impaired nutritional status, increased sleepiness, and decreased energy level, attentiveness, and cognitive tasking, … *Refractory to medical management Treatment Options for Kidney Failure ESRD Comfort Care Hemodialysis Peritoneal Dialysis Kidney Transplant ESRD, end-stage renal disease Treatment Options for Kidney Failure ESRD Comfort Care Hemodialysis Peritoneal Dialysis Kidney Transplant Dialysis Options Dialysis In-Center(dialysis clinic) Home In-Center Hemodialysis Peritoneal Dialysis -3 x week -Manual (CAPD) -Nocturnal -Cycler (CCPD) Home Hemodialysis -3-5 x/week -Day or nocturnal What is the most common modality to replace kidney function? A. In-Center(clinic) Hemodialysis B. Peritoneal
    [Show full text]
  • Home Hemodialysis with Nxstage
    Welcome to our August Webinar on Home Dialysis: Is It Your Best Treatment Option? We need your Feedback - Please complete after the program! This webinar will be recorded and slides will be available at www.dpcedcenter.org Next webinar on 9-27-18 with Edward Leigh on Communicating with your Healthcare Team: Top Tips to Prepare for Visits and Partner with Professionals! Reminder ➢ All phone lines are muted ➢ You can ask questions through the Chat Box ➢ Or, at the end of the presentation, you can ask questions by unmuting your phone (Unmute: #6, then Mute *6 ) ➢ Webinar Recording and slides will be available on our web site ➢ Please complete the feedback form at the end of the program ➢ Please share the information with others Join us next month on 9-27-18 for our webinar: Communicating with your Healthcare Team: Top Tips to Prepare for Visits and Partner with Professionals! Today’s Speakers Dr. Michael Kraus, MD, FACP Vanessa Evans Nephrologist, Patient Advocate Manager, Indiana University School of Medicine NxStage Medical, Inc. Associate Chief Medical Officer, Dialysis patient for 20 years, the last 13 years NxStage Medical, Inc. on more frequent home hemodialysis with NxStage. Page 3 Home Hemodialysis: Is it your best treatment option? Page 4 Agenda ▪ What are my treatment options? ▪ Why would I want to dialyze more than 3 days a week? ▪ Why would I want to go home? ▪ Vanessa’s Dialysis Story ▪ Questions and Answers What is your current dialysis therapy? What Are My Treatment Options? Page 7 Treatment Options: What do they mean? In-Center Hemodialysis Peritoneal Dialysis Home Hemodialysis Kidney Transplantation The traditional approach.
    [Show full text]